advertisement
Güven L 9
Showing records 1 to 9 | Display all abstracts from Güven L107914 Comprehensive Metabolite Profiling of Berdav Propolis Using LC-MS/MS: Determination of Antioxidant, Anticholinergic, Antiglaucoma, and Antidiabetic Effects
Karagecili H
Molecules 2023; 28:
108687 Screening of Antiglaucoma, Antidiabetic, Anti-Alzheimer, and Antioxidant Activities of Pall-Analysis of Phenolics Profiles by LC-MS/MS
Güven L; Güven L; Erturk A
Pharmaceuticals (Basel, Switzerland) 2023; 16:
107914 Comprehensive Metabolite Profiling of Berdav Propolis Using LC-MS/MS: Determination of Antioxidant, Anticholinergic, Antiglaucoma, and Antidiabetic Effects
Yılmaz MA
Molecules 2023; 28:
108687 Screening of Antiglaucoma, Antidiabetic, Anti-Alzheimer, and Antioxidant Activities of Pall-Analysis of Phenolics Profiles by LC-MS/MS
Miloğlu FD
Pharmaceuticals (Basel, Switzerland) 2023; 16:
107914 Comprehensive Metabolite Profiling of Berdav Propolis Using LC-MS/MS: Determination of Antioxidant, Anticholinergic, Antiglaucoma, and Antidiabetic Effects
Ertürk A; Kiziltas H
Molecules 2023; 28:
108687 Screening of Antiglaucoma, Antidiabetic, Anti-Alzheimer, and Antioxidant Activities of Pall-Analysis of Phenolics Profiles by LC-MS/MS
Alwasel S
Pharmaceuticals (Basel, Switzerland) 2023; 16:
107914 Comprehensive Metabolite Profiling of Berdav Propolis Using LC-MS/MS: Determination of Antioxidant, Anticholinergic, Antiglaucoma, and Antidiabetic Effects
Güven L
Molecules 2023; 28:
108687 Screening of Antiglaucoma, Antidiabetic, Anti-Alzheimer, and Antioxidant Activities of Pall-Analysis of Phenolics Profiles by LC-MS/MS
Gulcin İ
Pharmaceuticals (Basel, Switzerland) 2023; 16:
107914 Comprehensive Metabolite Profiling of Berdav Propolis Using LC-MS/MS: Determination of Antioxidant, Anticholinergic, Antiglaucoma, and Antidiabetic Effects
Güven L; Alwasel SH; Gulcin İ
Molecules 2023; 28:
